Genome-scale CRISPR-Cas9 knockout screening in primary renal tubule epithelial cells identifies ERAP2 as a potential target for cisplatin cytotoxicity
RNA-seq of HK-2 cells followed with ERAP2 inhibition and CDDP treatment